Letter
Squamous cell carcinoma complicating discoid lupus erythematosus in Chinese patients: Review of the literature, 1964-2010

https://doi.org/10.1016/j.jaad.2011.09.033Get rights and content

References (5)

  • L.G. Millard et al.

    Development of squamous cell carcinoma in chronic discoid lupus erythematosus

    Clin Exp Dermatol

    (1978)
  • D. de Berker et al.

    The sequelae of chronic cutaneous lupus erythematosus

    Lupus

    (1992)
There are more references available in the full text version of this article.

Cited by (27)

  • Skin

    2021, Lahita’s Systemic Lupus Erythematosus
  • Rapidly growing tumor on the scalp

    2019, JAAD Case Reports
  • Epidemiology of actinic keratosis

    2019, Annales de Dermatologie et de Venereologie
  • SnapshotDx Quiz: May 2019

    2019, Journal of Investigative Dermatology
  • Chronic Inflammation Promotes Skin Carcinogenesis in Cancer-Prone Discoid Lupus Erythematosus

    2019, Journal of Investigative Dermatology
    Citation Excerpt :

    Immunosuppressive medications used to treat cutaneous lupus, like mycophenolate mofetil, tacrolimus, and azathioprine, may promote SCC development by suppressing the antitumor immune response in the skin (Walling and Sontheimer, 2009). However, a similar prevalence of SCC is reported among DLE patients who never received systemic immunosuppressive medications (Tao et al., 2012). Inflammation and scarring are other potential risk factors for skin cancer.

  • Ocular, aural, and oral manifestations of lupus

    2018, Dubois' Lupus Erythematosus and Related Syndromes
View all citing articles on Scopus

Drs Tao and Zhang contributed equally to this letter.

Funding sources: None.

Conflicts of interest: None declared.

View full text